207 related articles for article (PubMed ID: 16739118)
1. Dopamine D2 and D3 receptors in human putamen, caudate nucleus, and globus pallidus.
Seeman P; Wilson A; Gmeiner P; Kapur S
Synapse; 2006 Sep; 60(3):205-11. PubMed ID: 16739118
[TBL] [Abstract][Full Text] [Related]
2. Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study.
Nakajima S; Caravaggio F; Boileau I; Chung JK; Plitman E; Gerretsen P; Wilson AA; Houle S; Mamo DC; Graff-Guerrero A
J Cereb Blood Flow Metab; 2015 Nov; 35(11):1812-8. PubMed ID: 26058690
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
Hillefors M; von Euler G
Neurochem Int; 2001 Jan; 38(1):31-42. PubMed ID: 10913686
[TBL] [Abstract][Full Text] [Related]
4. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
5. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
[TBL] [Abstract][Full Text] [Related]
6. The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO.
Graff-Guerrero A; Mamo D; Shammi CM; Mizrahi R; Marcon H; Barsoum P; Rusjan P; Houle S; Wilson AA; Kapur S
Arch Gen Psychiatry; 2009 Jun; 66(6):606-15. PubMed ID: 19487625
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 receptors mapped in rat brain with [3H](+)PHNO.
Nobrega JN; Seeman P
Synapse; 1994 Jul; 17(3):167-72. PubMed ID: 7974199
[TBL] [Abstract][Full Text] [Related]
9. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.
Graff-Guerrero A; Willeit M; Ginovart N; Mamo D; Mizrahi R; Rusjan P; Vitcu I; Seeman P; Wilson AA; Kapur S
Hum Brain Mapp; 2008 Apr; 29(4):400-10. PubMed ID: 17497628
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites.
Kiss B; Horti F; Bobok A
Synapse; 2011 Jun; 65(6):467-78. PubMed ID: 20936685
[TBL] [Abstract][Full Text] [Related]
11. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
Seeman P; Ko F; Willeit M; McCormick P; Ginovart N
Synapse; 2005 Nov; 58(2):122-8. PubMed ID: 16088951
[TBL] [Abstract][Full Text] [Related]
12. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
[TBL] [Abstract][Full Text] [Related]
13. Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925.
Graff-Guerrero A; Redden L; Abi-Saab W; Katz DA; Houle S; Barsoum P; Bhathena A; Palaparthy R; Saltarelli MD; Kapur S
Int J Neuropsychopharmacol; 2010 Apr; 13(3):273-87. PubMed ID: 19751545
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
McCormick PN; Kapur S; Seeman P; Wilson AA
Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
[TBL] [Abstract][Full Text] [Related]
15. D1 and D2 dopamine receptors in perinatal and adult basal ganglia.
Boyson SJ; Adams CE
Pediatr Res; 1997 Jun; 41(6):822-31. PubMed ID: 9167195
[TBL] [Abstract][Full Text] [Related]
16. Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia.
Martikainen IK; Hagelberg N; Mansikka H; Hietala J; Någren K; Scheinin H; Pertovaara A
Neurosci Lett; 2005 Mar; 376(3):149-53. PubMed ID: 15721212
[TBL] [Abstract][Full Text] [Related]
17. Reduced eticlopride-induced Fos expression in caudate-putamen and globus pallidus after unilateral frontal cortex injury: relation to neglect.
Vargo JM; Marshall JF
Neuroscience; 1997 Feb; 76(4):1083-95. PubMed ID: 9027868
[TBL] [Abstract][Full Text] [Related]
18. Dopamine receptors labelled by PHNO.
Seeman P; Ulpian C; Larsen RD; Anderson PS
Synapse; 1993 Aug; 14(4):254-62. PubMed ID: 7902615
[TBL] [Abstract][Full Text] [Related]
19. High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO.
Willeit M; Ginovart N; Kapur S; Houle S; Hussey D; Seeman P; Wilson AA
Biol Psychiatry; 2006 Mar; 59(5):389-94. PubMed ID: 16373068
[TBL] [Abstract][Full Text] [Related]
20. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]